Oncolytics Biotech Stocks ListRelated Stock Lists: Biopharmaceutical Cancer Cancer Therapeutics Cancer Therapy Chemical Compounds Chemistry Johnson & Johnson Metastatic Colorectal Cancer Ovarian Cancer Prostate Cancer RTT Solid Tumors Targeted Therapy Treating Cancer Treatment Of Cancer Treatment Of Ovarian Cancer
|2020-05-29||ONCX||Narrow Range Bar||Range Contraction|
|2020-05-29||ONCX||Stochastic Buy Signal||Bullish|
|2020-05-29||ONCX||Expansion Breakout||Bullish Swing Setup|
|2020-05-29||ONCX||Expansion Breakdown||Bearish Swing Setup|
|2020-05-29||ONCX||Jack-in-the-Box Bearish||Bearish Swing Setup|
|2020-05-29||ONCX||Jack-in-the-Box Bullish||Bullish Swing Setup|
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies. REOLYSIN is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.